Inna Vainshtein

770 total citations
26 papers, 510 citations indexed

About

Inna Vainshtein is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology and Molecular Biology. According to data from OpenAlex, Inna Vainshtein has authored 26 papers receiving a total of 510 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Radiology, Nuclear Medicine and Imaging, 13 papers in Immunology and 12 papers in Molecular Biology. Recurrent topics in Inna Vainshtein's work include Monoclonal and Polyclonal Antibodies Research (14 papers), T-cell and B-cell Immunology (6 papers) and Toxin Mechanisms and Immunotoxins (6 papers). Inna Vainshtein is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (14 papers), T-cell and B-cell Immunology (6 papers) and Toxin Mechanisms and Immunotoxins (6 papers). Inna Vainshtein collaborates with scholars based in United States, Slovakia and Australia. Inna Vainshtein's co-authors include Meina Liang, Lorin Roskos, Amy Schneider, Martin Schwickart, Raffaella Faggioni, Jackie Cheng, Hong Lü, Richard A. Roth, Bhargavi Rajan and Matthew A. Sleeman and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Inna Vainshtein

26 papers receiving 463 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Inna Vainshtein United States	13	221	211	210	140	119	26	510
James Hunt United Kingdom	12	317 1.4×	277 1.3×	229 1.1×	56 0.4×	121 1.0×	17	662
Anwar Murtaza United States	9	296 1.3×	258 1.2×	284 1.4×	31 0.2×	153 1.3×	13	596
Marie-Pierre Gras France	8	258 1.2×	88 0.4×	207 1.0×	40 0.3×	149 1.3×	12	525
Jennifer Fraszczak Canada	13	415 1.9×	34 0.2×	201 1.0×	115 0.8×	117 1.0×	23	725
Laurence Fayadat‐Dilman United States	11	130 0.6×	232 1.1×	260 1.2×	25 0.2×	145 1.2×	20	487
Sabine Münkel Germany	10	321 1.5×	118 0.6×	306 1.5×	14 0.1×	167 1.4×	10	565
M. Marino Italy	6	87 0.4×	92 0.4×	145 0.7×	26 0.2×	61 0.5×	7	404
K Zinkewich-Péotti Canada	10	42 0.2×	116 0.5×	298 1.4×	21 0.1×	157 1.3×	15	502
D. Berry United States	8	186 0.8×	117 0.6×	157 0.7×	85 0.6×	41 0.3×	12	484
Gadi Gazit Bornstein United States	6	104 0.5×	189 0.9×	151 0.7×	10 0.1×	101 0.8×	9	335

Countries citing papers authored by Inna Vainshtein

Since Specialization

Citations

This map shows the geographic impact of Inna Vainshtein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inna Vainshtein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inna Vainshtein more than expected).

Fields of papers citing papers by Inna Vainshtein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Inna Vainshtein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inna Vainshtein. The network helps show where Inna Vainshtein may publish in the future.

Co-authorship network of co-authors of Inna Vainshtein

This figure shows the co-authorship network connecting the top 25 collaborators of Inna Vainshtein. A scholar is included among the top collaborators of Inna Vainshtein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Inna Vainshtein. Inna Vainshtein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mendelsohn, Brian A., Kathleen R. Gogas, Jeffrey N. Higaki, et al.. (2025). Preclinical Characterization of XB010: A Novel Antibody–Drug Conjugate for the Treatment of Solid Tumors that Targets Tumor-Associated Antigen 5T4. Molecular Cancer Therapeutics. 24(12). 1856–1866. 1 indexed citations

Kantak, Seema, Raffaella Faggioni, Inna Vainshtein, et al.. (2024). Preclinical Characterization of XB002, an Anti–Tissue Factor Antibody–Drug Conjugate for the Treatment of Solid Tumors. Molecular Cancer Therapeutics. 24(2). 251–260. 1 indexed citations

Li, Jing, Philip Z. Brohawn, Bo Sun, et al.. (2023). Combining pharmacometric models with predictive and prognostic biomarkers for precision therapy in Crohn's disease: A case study of brazikumab. CPT Pharmacometrics & Systems Pharmacology. 12(12). 1945–1959. 5 indexed citations

Liang, Meina, Bing Wang, Amy Schneider, Inna Vainshtein, & Lorin Roskos. (2020). A Novel Pharmacodynamic Biomarker and Mechanistic Modeling Facilitate the Development of Tovetumab, a Monoclonal Antibody Directed Against Platelet-Derived Growth Factor Receptor Alpha, for Cancer Therapy. The AAPS Journal. 23(1). 4–4. 4 indexed citations

Cheng, Jackie, Meina Liang, Miguel F. Carvalho, et al.. (2020). Molecular Mechanism of HER2 Rapid Internalization and Redirected Trafficking Induced by Anti-HER2 Biparatopic Antibody. SHILAP Revista de lepidopterología. 9(3). 49–49. 39 indexed citations

Vainshtein, Inna, Bo Sun, Lorin Roskos, & Meina Liang. (2019). A novel approach to assess domain specificity of anti-drug antibodies to moxetumomab pasudotox, an immunotoxin with two functional domains. Journal of Immunological Methods. 477. 112688–112688. 7 indexed citations

Hemken, Philip M., Tracey Rae, Ying Xu, et al.. (2017). Development and analytical performance of a new ARCHITECT automated dipeptidyl peptidase-4 immunoassay. Practical Laboratory Medicine. 9. 58–68. 9 indexed citations

Schneider, Amy, Inna Vainshtein, Lorin Roskos, et al.. (2016). An immunoinhibition approach to overcome the impact of pre-existing antibodies on cut point establishment for immunogenicity assessment of moxetumomab pasudotox. Journal of Immunological Methods. 435. 68–76. 9 indexed citations

Ranade, Koustubh, Michael Kuziora, Tuyet‐Hang Pham, et al.. (2016). Dipeptidyl peptidase-4 (DPP-4) may predict response to tralokinumab in patients with asthma. OA1796–OA1796. 1 indexed citations

10.

Liang, Meina, Martin Schwickart, Amy Schneider, et al.. (2015). Receptor occupancy assessment by flow cytometry as a pharmacodynamic biomarker in biopharmaceutical development. Cytometry Part B Clinical Cytometry. 90(2). 117–127. 36 indexed citations

11.

Vainshtein, Inna, Amy Schneider, Bo Sun, et al.. (2015). Multiplexing of receptor occupancy measurements for pharmacodynamic biomarker assessment of biopharmaceuticals. Cytometry Part B Clinical Cytometry. 90(2). 128–140. 7 indexed citations

12.

Vainshtein, Inna, Lorin Roskos, Jackie Cheng, et al.. (2014). Quantitative Measurement of the Target-Mediated Internalization Kinetics of Biopharmaceuticals. Pharmaceutical Research. 32(1). 286–299. 26 indexed citations

13.

Higgs, Brandon W., Linda Chang, Inna Vainshtein, et al.. (2013). Pharmacogenomics and Translational Simulations to Bridge Indications for an Anti-Interferon-α Receptor Antibody. Clinical Pharmacology & Therapeutics. 93(6). 483–492. 49 indexed citations

14.

Cohen, E. Suzanne, Meina Liang, Inna Vainshtein, et al.. (2012). Protein engineering and preclinical development of a GM‐CSF receptor antibody for the treatment of rheumatoid arthritis. British Journal of Pharmacology. 168(1). 200–211. 22 indexed citations

15.

Wang, Bing, Meina Liang, Zhenling Yao, et al.. (2012). Pharmacokinetic and Pharmacodynamic Comparability Study of Moxetumomab Pasudotox, an Immunotoxin Targeting CD22, in Cynomolgus Monkeys. Journal of Pharmaceutical Sciences. 102(1). 250–261. 8 indexed citations

16.

Wang, Bing, Yvonne Lau, Meina Liang, et al.. (2011). Mechanistic Modeling of Antigen Sink Effect for Mavrilimumab Following Intravenous Administration in Patients With Rheumatoid Arthritis. The Journal of Clinical Pharmacology. 52(8). 1150–1161. 24 indexed citations

17.

Zhao, Xiaoning, et al.. (2003). Homogeneous Assays for Cellular Protein Degradation Using β -Galactosidase Complementation: NF- κ B/I κ B Pathway Signaling. Assay and Drug Development Technologies. 1(6). 823–833. 15 indexed citations

18.

Vainshtein, Inna, Kristina S. Kovacina, & Richard A. Roth. (2001). The Insulin Receptor Substrate (IRS)-1 Pleckstrin Homology Domain Functions in Downstream Signaling. Journal of Biological Chemistry. 276(11). 8073–8078. 22 indexed citations

19.

Vainshtein, Inna, Bruce A. Malcolm, Alexey Atrazhev, et al.. (1996). Peptide rescue of an N‐terminal truncation of the stoffel fragment of Taq DNA polymerase. Protein Science. 5(9). 1785–1792. 13 indexed citations

20.

Kriangkum, Jitra, Inna Vainshtein, & John F. Elliott. (1992). A reliable method for amplifying cDNA using the anchored-polymerase chain reaction (A-PCR). Nucleic Acids Research. 20(14). 3793–3794. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact